All In Biotech

Drug Trial Radar · NCT04376554

Effect of Tebipenem on Normal Human Intestinal Microbiota

Phase 1 Study to Evaluate the Effect of Oral Administration of Tebipenem Pivoxil Hydrobromide on Normal Human Intestinal Microbiota in Healthy Volunteers

Last checked: Nov 19, 2026Latest source record: May 4, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

30

Actual

Start

Feb 10, 2020

Primary completion

Apr 6, 2021

Study completion Apr 6, 2021

Sponsor

Lead sponsor
Spero TherapeuticsIndustry
Sponsor type
Industry
Collaborators
IQVIA Pty Ltd
First posted
May 6, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The overall purpose of this study is to support the development of an oral formulation of TBPM-PI-HBr by assessing the potential ecological effects of tebipenem on the normal intestinal microbiota as compared to the effects of oral amoxicillin-clavulanate.

Conditions

  • Healthy Volunteers

Interventions

  • TBPM-PI-HBrDrug

    TBPM-PI-HBr (2 x 300mg tablets) PO q8h \[±1 hour\] for 10 days

  • amoxicillin-clavulanateDrug

    amoxicillin-clavulanate (1 × 500mg/125mg tablet) PO q8h \[±1 hour\] for 10 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in the number of microorganisms in the intestinal flora of healthy subjects during and after 10 days of oral administration of TBPM-PI-HBr or amoxicillin-clavulanateTime frame: Change from baseline (Day-1), at Days 2, 4, 7, 10, 14, 21, 90, and 180
  2. Changes in the types of microorganisms in the intestinal flora of healthy subjects during and after 10 days of oral administration of TBPM-PI-HBr or amoxicillin-clavulanateTime frame: Change from baseline (Day-1), at Days 2, 4, 7, 10, 14, 21, 90, and 180

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Karolinska University Hospital

    Huddinge, Stockholm County, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.